Last reviewed · How we verify
Sequence 6
At a glance
| Generic name | Sequence 6 |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic and Subjective Effects of Heated Tobacco Products (NA)
- Study in Adult Patients With Moderate to Severe Asthma (PHASE3)
- Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction (NA)
- A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood (PHASE1)
- A Study to Investigate the Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet Containing Zanubrutinib and Sonrotoclax (BG-71332) in Healthy Adults (PHASE1)
- Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging (NA)
- Nutrition for Precision Health, Powered by the All of Us (NA)
- Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sequence 6 CI brief — competitive landscape report
- Sequence 6 updates RSS · CI watch RSS
- Chong Kun Dang Pharmaceutical portfolio CI